Document is current
Any future updates will be listed below
-
Authors
Rapöhn, Inka https://orcid.org/0000-0001-7997-5334
Broghammer, Helen
Hoffmann, Anne https://orcid.org/0000-0003-3258-3397
Möhlis, Kevin
Moormann, Anna
Kaczmarek, Isabell https://orcid.org/0000-0001-9774-3959
Thor, Doreen https://orcid.org/0000-0002-9522-5098
Großkopf, Henning https://orcid.org/0000-0002-5122-2477
Krieg, Laura
Karkossa, Isabel https://orcid.org/0000-0003-2781-1877
Schubert, Kristin https://orcid.org/0000-0003-4365-084X
von Bergen, Martin https://orcid.org/0000-0003-2732-2977
Krause, Kerstin https://orcid.org/0000-0003-1766-3698
Breitfeld, Jana https://orcid.org/0000-0001-8346-8087
Kovacs, Peter https://orcid.org/0000-0002-0290-5423
Klöting, Nora
Nuwayhid, Rima https://orcid.org/0000-0001-7587-1968
Langer, Stefan
Ghosh, Adhideb
Wolfrum, Christian https://orcid.org/0000-0002-3862-6805
Stumvoll, Michael https://orcid.org/0000-0001-6225-8240
Blüher, Matthias https://orcid.org/0000-0003-0208-2065
Heiker, John T. https://orcid.org/0000-0003-2822-3006
Weiner, Juliane
-
Funding
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (209933838)
- License Information
-
More Information
Article History
Received: 29 July 2024
Accepted: 13 November 2025
First Online: 10 December 2025
Competing interests
: M.B. received honoraria as a consultant and speaker from Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Lilly, Novo Nordisk, Novartis, and Sanofi. All other authors declare no conflicts of interest. The funders had no role in the design of the study, the collection, analyses, or interpretation of data, in the decision to publish the results and the writing of the manuscript.
